Skip to content
12 March 2024

NHS England Bans Puberty Blockers for Under-18s

Discrimination Health Legal Trans UK

NHS England announced that puberty-suppressing hormones would no longer be routinely prescribed to children and young people with gender dysphoria outside of clinical research settings. The decision followed recommendations from the interim Cass Review and was subsequently reinforced by emergency legislation in May 2024 extending the ban to private prescriptions.

Impact & Significance

Represented the most significant restriction on trans youth healthcare in UK history, drawing both support from those advocating caution and fierce criticism from trans rights organisations who argued it denied essential care.

Reference Record

Date
12 March 2024
Era
2020-present
Sources
2

This timeline entry is being migrated into the reference platform. Source metadata and editorial review status will be strengthened as each topic is upgraded.

Share